Abstract
Positron emission tomography (PET) scanning with F18-fluorodeoxyglucose or FDG is a becoming a standard method for tumor staging. The prediction and evaluation of therapy response are newer applications of FDG-PET. PET often offers an early read-out of treatment efficacy and is an attractive alternative to conventional anatomic assessments of treatment response. This article reviews the methods available with PET tomonitor therapy response. Disease specific applications of PET imaging are then reviewed. While FDG is the most commonly used radiotracer for PET, many other radioligands could be applied in the future.
| Original language | English (US) |
|---|---|
| Pages (from-to) | 119-134 |
| Number of pages | 16 |
| Journal | Cancer Journal |
| Volume | 8 |
| Issue number | 2 |
| DOIs | |
| State | Published - Apr 1 2002 |
| Externally published | Yes |
Keywords
- Cancer
- FDG
- Fluorodeoxyglucose
- PET
- Positron emission tomography
- Radionuclide imaging
- Response
- Therapy
ASJC Scopus subject areas
- Oncology
- Cancer Research